Delivery Order SPE2DB22D1002-SPE2DB26FKST6
Award Date 10/14/25
Potential Completion Date 10/15/25
Potential Value $5.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,321.58 delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (quantity: 7 units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Orilissa 200 mg tablets (14-count packaging) with a ceiling value of $8,559.49 under a firm fixed-price contract. This non-set-aside award was competitively procured and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Orilissa 150 mg tablets (seven-count packages) under a firm fixed-price contract valued at $4,756.11, with completion scheduled for September 8, 2025. This non-set-aside competitive award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a delivery order valued at $7,530.90 to AmerisourceBergen Drug Corp for Orilissa 150 mg tablets (7-count packages) on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed price delivery order represents a non-competitive set-aside procurement and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was selected to supply this specialized...
- The Defense Logistics Agency awarded a delivery order valued at $1,205.70 to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (quantity 7) on April 29, 2025, with completion scheduled for April 30, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Orilissa is a prescription medication used in women's healthcare, reflecting the broad...
- The Defense Logistics Agency awarded a delivery order valued at $6,308.10 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Orilissa 150 mg tablets (7-count packaging). This is a firm fixed-price, non-set-aside contract with a completion date of July 21, 2025, and performance in Conshohocken, Pennsylvania. Orilissa is an endometriosis treatment medication, representing the type of specialized pharmaceutical product that AmerisourceBergen routinely supplies to federal...
- The Defense Logistics Agency awarded a $68,576.46 delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (seven-count units) under a firm fixed price contract. The contract was competitively awarded with no set-aside designation and includes an ultimate completion date of September 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,493.91 to AmerisourceBergen Drug Corp for 7 tablets of Orilissa 150 mg on September 8, 2025, with a completion date of September 9, 2025. This firm fixed-price delivery order, which is not a set-aside contract, represents a procurement of the endometriosis medication Orilissa to support federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $8,143.08 to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (7-count packages) on September 24, 2025, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (quantity 7) under a firm fixed price contract valued at $2,280.66. The award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...